Host-directed kinase inhibitors act as novel therapies against intracellular Staphylococcus aureus

Host-directed therapeutics are a promising anti-infective strategy against intracellular bacterial pathogens. Repurposing host-targeted drugs approved by the FDA in the US, the MHRA in the UK and/or regulatory equivalents in other countries, is particularly interesting because these drugs are commer...

Descripción completa

Detalles Bibliográficos
Autores principales: Bravo-Santano, Natalia, Stölting, Helen, Cooper, Frederic, Bileckaja, Narina, Majstorovic, Andrea, Ihle, Nadine, Mateos, Luis M., Calle, Yolanda, Behrends, Volker, Letek, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425000/
https://www.ncbi.nlm.nih.gov/pubmed/30890742
http://dx.doi.org/10.1038/s41598-019-41260-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425000/
https://www.ncbi.nlm.nih.gov/pubmed/30890742
http://dx.doi.org/10.1038/s41598-019-41260-8

Ejemplares similares